Clinical response to bevacizumab in schwannomatosis.

Abstract

Supplemental data at Neurology.org CLINICAL RESPONSE TO BEVACIZUMAB IN SCHWANNOMATOSIS Schwannomatosis is a neurogenetic syndrome characterized by schwannomas throughout the peripheral nervous system without bilateral vestibular schwannomas (VS) or germline neurofibromatosis 2 (NF2) mutation. Management is difficult due to large tumor burden and treatment… (More)
DOI: 10.1212/WNL.0000000000000997

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics